This announcement is a separate document:
麗珠醫藥：(I)向麗珠生物增資 (II)回購本公司部分A股股份方案 (III)授予董事會回購本公司H股的一般授權 (IV)召開臨時股東大會、A股類別股東會及H股類別股東會
LIVZON PHARMA: (I) CAPITAL CONTRIBUTION TO LIVZONBIO (II) REPURCHASE OF PART OF THE COMPANY''S A SHARES SCHEME (III) GRANT OF GENERAL MANDATE TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY (IV) CONVENING THE EGM, THE A SHAREHOLDERS'' CLASS MEETING AND
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.